Tailored Management for the Three Highs

Autologous adipose-derived svCell therapy has a reduced risk of adverse reactions or serious side effects.

As the treatment is autologous, with the svCell regenerative cells derived from the patient’s own body, there is a lower risk of infection or disease transmission. Using the patient’s own, uncultured cells reduces potential risks and complications as associated with rejection and allergic reactions.

The ultrasonic cavitation concentration process does not use any enzymes or animal products.. Within a relatively short period of time, potentially within 4 hours, the patient’s cells are concentrated and injected. As a result, there is a reduced chance of infection, disease transmission, bacterial contamination, or allergic reaction.

Over the last 12 years, there has been a body of evidence in peer-reviewed scientific literature supporting the safety of svCell in the treatment of osteoarthritis for knee and hip disease.

The svCell therapy procedure involves removing adipose (fat) tissue from the patient’s abdomen, concentrating a mixture of cells, and then re-injecting the cell concentration into the patient’s painful joint(s).

In Australia svCell therapy procedures must be conducted within an accredited hospital setting under medical supervision with patient’s admitted to the hospital as a day surgery patient. The procedure is usually completed within 4 hours after which the patient may go home.

Preparation

Patients taking Aspirin, anti-inflammatory medications (such as Voltaren and Mobic), corticosteroids, or herbal medications (e.g., Krill oil, fish oil, Vitamin E, and Ginkho Biloba) are advised that these must be discontinued at least 10 days before the procedure, according to standard hospital admission instructions. Those patients taking aspirin (Cartia, etc.), clopidogrel (Plavix or Iscover), warfarin, or anticoagulants for a heart condition or stroke prevention, would be provided specific information by their own doctor on when to stop and restart these medications.

Removal of adipose tissue

Patients receive oral sedation, and local anesthetic, and may be prescribed an antibiotic to reduce the risk of infection and are expected to be comfortable, and relatively pain-free.

A syringe or miniliposuction method is used to extract 60-300ml of adipose (fat) tissue from the patient’s abdomen, as that is all that is required. The amount of fat consumed will be determined by the number of joints to be treated. The treating doctor will explain the method of fat extraction to be used prior to the procedure. Because the procedure is minimally invasive, no stitches are usually needed.

Collect regenerative cells

Following adipose tissue removal, a sterile laboratory technician immediately performs the svCell ultrasonic cavitation process to concentrate the patient’s regenerative cells. A flow cytometer is used to count cells and viability and determine the best dosage for the injection of svCell concentrate.

Injection

The injection site is prepared in advance. A Doctor will then inject the svCells into the joint(s).

Where necessary, ultrasound guidance can be used to guide needle placement.

After the injection, patients are monitored for 1 hour before being released to go home.